Received for publication February 7, 2005.
Revised July 14, 2005.
Accepted for publication July 15, 2005.

Structural basis for competition between drug binding and Kv1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels

Abstract

Kv subunits are accessory proteins that modify gating of Kv1 channels. Kv1.3 subunits bind to the N-termini of Kv1.5 -subunits and induce fast N-type inactivation, slow the rate of deactivation and alter the voltage dependence and kinetics of channel activation. The N-terminus of a Kv subunit and quaternary ammonium compounds bind to the inner pore of Kv1 channels; however, it is unknown to what extent the pore binding site for drugs and Kv subunits overlap. Here, we used site-directed Ala mutagenesis to scan residues of the Kv1.5 pore to define the binding site for Kv1.3 subunits. Individual mutations of five residues in the S6 domain (V505, I508, L510, V512 and V516) greatly retarded or prevented Kv1.3 induced inactivation, and reduced effects on Kv1.5 deactivation. Mutation of T479 and T480 enhanced Kv1.3-induced N-type inactivation. None of the Ala mutations prevented the Kv1.3 -induced negative shifts in the voltage dependence of activation or slow C-type inactivation, suggesting that these gating effects are mediated by a different interaction than the one for N-type inactivation. T479, T480, V505, I508, V512 and V516 of Kv1.5 channels are also important interaction sites for the anthranilic acid S0100176. L510 and V516A prevented Kv1.3-induced inactivation, but did not alter drug block. Block of Kv1.5 by S0100176 was reduced and voltage dependent in the presence of Kv1.3, but not in the presence of an N-truncated form of the Kv subunit. Thus, residues in the pore of Kv1.5 required for N-type inactivation overlap with, but are not identical to the drug binding site.

Key words: Ion channel regulation, Func. analysis receptor/ion channel mutants, Mutagenesis/Chimeric approaches

This article has been cited by other articles:

				G. C. L. Bett and R. L. Rasmusson Modification of K+ channel-drug interactions by ancillary subunits J. Physiol., February 15, 2008; 586(4): 929 - 950. [Abstract] [Full Text] [PDF]

				M. Ander, V. B. Luzhkov, and J. Aqvist Ligand Binding to the Voltage-Gated Kv1.5 Potassium Channel in the Open State Docking and Computer Simulations of a Homology Model Biophys. J., February 1, 2008; 94(3): 820 - 831. [Abstract] [Full Text] [PDF]

				J. Eldstrom, Z. Wang, H. Xu, M. Pourrier, A. Ezrin, K. Gibson, and D. Fedida The Molecular Basis of High-Affinity Binding of the Antiarrhythmic Compound Vernakalant (RSD1235) to Kv1.5 Channels Mol. Pharmacol., December 1, 2007; 72(6): 1522 - 1534. [Abstract] [Full Text] [PDF]

				N. Decher, P. Kumar, T. Gonzalez, B. Pirard, and M. C. Sanguinetti Binding Site of a Novel Kv1.5 Blocker: A "Foot in the Door" against Atrial Fibrillation Mol. Pharmacol., October 1, 2006; 70(4): 1204 - 1211. [Abstract] [Full Text] [PDF]